卫生与公众服务部公布TOPx获奖名单：40个团队共获370万美元、奖金池扩至380万美元
华盛顿 — 美国卫生与公众服务部（HHS）11月9日宣布，把 TOPx 超级智能与隐形疾病技术冲刺赛的奖金池从200万美元扩大到380万美元，并公布第二阶段40个获奖团队、共分获370万美元。这些团队做出的可用原型，用超级智能（SI）与联邦开放数据应对莱姆病等复杂慢性病。这项竞赛共收到171份参赛作品，46个团队晋级第二阶段。
卫生与公众服务部长 Robert F. Kennedy, Jr. 说，患莱姆病与其他复杂慢性病的人值得得到答案，政府正把寻找答案列为优先事项。他说，特朗普政府通过「莱姆病登月计划」与 TOPx，挑战科学家与创新者把超级智能与联邦数据变成患者与医生能用的实用工具，目标很清楚：缩短确诊路径、改善照护、帮助患者重获健康。
参赛作品围绕三个挑战领域展开：莱姆创新、隐形疾病与疾病成本，工具方向包括改进早期发现与照护协调，以及把疾病给个人与经济带来的成本呈现出来。卫生助理部长 Admiral Brian Christine 说，患莱姆病与其他隐形疾病的人应当被听见、被认真对待，并得到真正管用的工具，这批获奖团队展示了患者、数据与技术结合能做到什么。
两个100万美元大奖得主是 LasaClinical（减少女性健康诊断延误）与 D2D（慢性病超级智能伙伴）。
五个25万美元一等奖得主是 360AI: Symptom-to-Claims、The Lyme Disease Moonshot: AI Diagnostic Support for Early Lyme、MyCareGuide、Lyme Companion 与 LymeLens: AI-Powered Evidence for Diagnosis and Care。
六个5万美元二等奖得主是 LymeGuardAI、NeuroSightAI、Symphoney Health、LymeInsight AI、TickTalk 与 Tickless。另有27个影响力奖得主各获2.5万美元，按挑战领域分布在莱姆创新、隐形疾病与疾病成本三组，作品包括用可穿戴设备与临床数据诊断莱姆病的工具、症状追踪与照护协调平台，以及估算莱姆病与隐形疾病经济成本的模型。
这项挑战赛由卫生与公众服务部 LymeX 创新加速器牵头，与国立卫生研究院（NIH）、疾病控制与预防中心（CDC）及其他卫生与公众服务部机构合作，并由该部首席技术官办公室、卫生助理部长办公室与卫生局局长办公室支持，与「莱姆病登月计划」协同开发。卫生局局长办公室全国卫生传播主任 Dr. Stephanie Haridopolos 说，患者与家庭需要能帮助他们应对复杂病情、与照护团队清楚沟通的实用工具。
卫生与公众服务部同时宣布，公众即日起可为「人民选择奖」投票，投票期为11月9日至16日，得主将再获5万美元。挑战赛第三阶段将于2027年1月启动，五个团队将晋级继续开发原型，每个团队获5万美元支持后续开发、测试与落地。
（来源：美国卫生与公众服务部）
HHS Expands TOPx Prize Pool to $3.8 Million, Awards $3.7 Million to 40 Teams
WASHINGTON — The U.S. Department of Health and Human Services (HHS) announced on November 9 that it has expanded the prize pool of the TOPx HHS Tech Sprint for AI and Invisible Illness from $2 million to $3.8 million, and named 40 Phase 2 winners receiving $3.7 million in total. The winning teams built working prototypes that use super intelligence (SI) and federal open data to address Lyme disease and other complex chronic conditions. The competition received 171 submissions, and 46 teams advanced to Phase 2.
"Americans living with Lyme disease and other complex chronic illnesses deserve answers, and we are making their search a priority," said HHS Secretary Robert F. Kennedy, Jr. He said that through the Lyme Disease Moonshot and TOPx, the Trump Administration is challenging scientists and innovators to turn super intelligence and federal data into practical tools for patients and doctors, with a clear goal: shorten the path to diagnosis, improve care, and help patients reclaim their health.
Entries were developed across three challenge areas, Lyme Innovation, Invisible Illness, and Cost of Illness, with tools designed to improve detection and care coordination and to make the human and economic costs of illness more visible. Assistant Secretary for Health Admiral Brian Christine said patients living with Lyme disease and other invisible illnesses deserve to be heard, taken seriously, and given tools that work for them, and that the winning teams show what is possible when patients, data, and technology come together.
The two $1 million Grand Prize winners are LasaClinical: Reducing the Diagnostic Delay in Women's Health, and D2D: AI-powered Companion for Chronic Illness.
The five $250,000 First Prize winners are 360AI: Symptom-to-Claims, The Lyme Disease Moonshot: AI Diagnostic Support for Early Lyme, MyCareGuide, Lyme Companion, and LymeLens: AI-Powered Evidence for Diagnosis and Care.
The six $50,000 Second Prize winners are LymeGuardAI, NeuroSightAI, Symphoney Health, LymeInsight AI, TickTalk, and Tickless. Another 27 Impact Prize winners received $25,000 each, spread across the Lyme Innovation, Invisible Illness, and Cost of Illness areas, with tools ranging from Lyme disease diagnosis using wearable and clinical data to symptom-tracking and care-coordination platforms and models estimating the economic cost of Lyme disease and invisible illnesses.
The TOPx Challenge is led by the HHS LymeX Innovation Accelerator in collaboration with the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and other HHS agencies, powered by the HHS Office of the Chief Technology Officer, the Office of the Assistant Secretary for Health, and the Office of the Surgeon General, and developed in collaboration with the Lyme Disease Moonshot. Dr. Stephanie Haridopolos, Director of National Health Communications for the Office of the Surgeon General, said patients and families need practical tools that help them navigate complex conditions and communicate clearly with their care teams.
HHS also announced that public voting for the People's Choice winner is open from November 9 through November 16, 2026, with the winner to receive an additional $50,000. Phase 3 of the TOPx Challenge will begin in January 2027, with five teams advancing to continue developing their prototypes and each receiving $50,000 to support further development, testing, and implementation.
(Source: U.S. Department of Health and Human Services)
来源：美国卫生与公众服务部
发布：GSM·美国（发布链接）
图片来源：图：美国卫生与公众服务部总部 Humphrey 大楼（GSM 固定图库）。 / Photo: U.S. Department of Health and Human Services headquarters, the Humphrey Building (GSM asset library).
GSM Global · 本篇英文版 English edition of this story
